{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:35:35Z","timestamp":1790008535817,"version":"4.0.1"},"reference-count":262,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T00:00:00Z","timestamp":1567382400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007393","name":"Association Fran\u00c3\u00a7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Bioenergetics"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbabio.2018.05.003","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T13:15:41Z","timestamp":1525785341000},"page":"845-867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["RAS signalling in energy metabolism and rare human diseases"],"prefix":"10.1016","volume":"1859","author":[{"given":"L.","family":"Dard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bellance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbabio.2018.05.003_bb0005","first-page":"1989494682","article-title":"ras Oncogenes in human cancer: a review","author":"Bos","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","article-title":"RAS proteins and their regulators in human disease","volume":"170","author":"Simanshu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jmedgenet-2013-101951","article-title":"Autism traits in the RASopathies","volume":"51","author":"Adviento","year":"2014","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1152\/physrev.00003.2012","article-title":"Regulation of small GTPases by GEFs, GAPs, and GDIs","volume":"93","author":"Cherfils","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2007.05.018","article-title":"GEFs and GAPs: critical elements in the control of small G proteins","volume":"129","author":"Bos","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0030","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.cellsig.2010.05.010","article-title":"RalGDS family members couple Ras to Ral signalling and that's not all","volume":"22","author":"Ferro","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1947601911408079","article-title":"RAS interaction with PI3K: more than just another effector pathway","volume":"2","author":"Castellano","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/369411a0","article-title":"Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane","volume":"369","author":"Leevers","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0045","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.7811320","article-title":"Activation of Raf as a result of recruitment to the plasma membrane","volume":"264","author":"Stokoe","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0050","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/1541-7786.MCR-15-0203","article-title":"Biochemical and structural analysis of common cancer-associated KRAS mutations","volume":"13","author":"Hunter","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/02699050500284218","article-title":"The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions","volume":"24","author":"Yoon","year":"2006","journal-title":"Growth Factors"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","article-title":"The RASopathies","volume":"14","author":"Rauen","year":"2013","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0065","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1242\/dmm.020339","article-title":"RASopathies: unraveling mechanisms with animal models","volume":"8","author":"Jindal","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0070","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0075","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1002\/ajmg.a.31547","article-title":"A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in theNF1 gene","volume":"140A","author":"H\u00fcffmeier","year":"2006","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0080","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1399-0004.2006.00576.x","article-title":"Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype: NF-Noonan syndrome","volume":"69","author":"Stevenson","year":"2006","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0085","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(09)70033-6","article-title":"Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1","volume":"10","author":"Brems","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","article-title":"A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations","volume":"62","author":"Cawthon","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ng0293-122","article-title":"Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis","volume":"3","author":"Legius","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0110","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1101\/gad.8.9.1019","article-title":"Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues","volume":"8","author":"Brannan","year":"1994","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng0794-353","article-title":"Tumour predisposition in mice heterozygous for a targeted mutation in Nf1","volume":"7","author":"Jacks","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/dbio.1999.9327","article-title":"Neurofibromin deficiency in mice causes exencephaly and is a modifier for splotch neural tube defects","volume":"212","author":"Lakkis","year":"1999","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0125","doi-asserted-by":"crossref","DOI":"10.1172\/JCI28341","article-title":"The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1\u2212\/\u2212 mice","author":"Ismat","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0130","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1242\/dev.125.22.4359","article-title":"Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart","volume":"125","author":"Lakkis","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0135","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1093\/hmg\/ddn134","article-title":"Nf1+\/\u2212 mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway","volume":"17","author":"Lasater","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0140","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1161\/CIRCULATIONAHA.107.707752","article-title":"NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response","volume":"116","author":"Xu","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/ng0397-281","article-title":"A mouse model for the learning and memory deficits associated with neurofibromatosis type I","volume":"15","author":"Silva","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0150","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1601-183X.2011.00685.x","article-title":"Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum","volume":"10","author":"van der Vaart","year":"2011","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0155","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/nn.3822","article-title":"Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase","volume":"17","author":"Molosh","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066024","article-title":"Motivational disturbances and effects of l-dopa administration in neurofibromatosis-1 model mice","volume":"8","author":"Wozniak","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0165","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1093\/hmg\/ddq382","article-title":"Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice","volume":"19","author":"Brown","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0170","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1073\/pnas.1004829107","article-title":"Neurofibromin regulates corticostriatal inhibitory networks during working memory performance","volume":"107","author":"Shilyansky","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0175","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.pediatrneurol.2011.06.016","article-title":"Lovastatin as treatment for neurocognitive deficits in Neurofibromatosis type 1: phase I study","volume":"45","author":"Acosta","year":"2011","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0180","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","article-title":"The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1","volume":"15","author":"Li","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0185","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.cell.2012.06.034","article-title":"ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities","volume":"150","author":"Wang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0190","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ccell.2014.09.009","article-title":"Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma","volume":"26","author":"Chen","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0195","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.celrep.2013.08.033","article-title":"Injury signals cooperate with Nf1 loss to relieve the tumor-suppressive environment of adult peripheral nerve","volume":"5","author":"Ribeiro","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0200","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.stem.2009.03.017","article-title":"Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas","volume":"4","author":"Le","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0205","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1126\/science.286.5447.2176","article-title":"Mouse tumor model for neurofibromatosis type 1","volume":"286","author":"Vogel","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0210","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1126\/science.286.5447.2172","article-title":"Mouse models of tumor development in neurofibromatosis type 1","volume":"286","author":"Cichowski","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0215","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/107385849700300614","article-title":"Neurofibromatosis type 1: genetic and cellular mechanisms of peripheral nerve tumor formation","volume":"3","author":"Rosenbaum","year":"1997","journal-title":"Neuroscientist"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0220","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/0008-5472.CAN-05-1480","article-title":"An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model","volume":"66","author":"Reilly","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0225","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1158\/0008-5472.CAN-09-2178","article-title":"The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivo","volume":"70","author":"Banerjee","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0230","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI60578","article-title":"MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors","volume":"123","author":"Jessen","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0235","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.18632\/oncotarget.1609","article-title":"Co-targeting the MAPK and PI3K\/AKT\/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity","volume":"5","author":"Watson","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0240","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/35002593","article-title":"A neurofibromatosis-1-regulated pathway is required for learning in Drosophila","volume":"403","author":"Guo","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0245","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1523\/JNEUROSCI.0933-07.2007","article-title":"Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation","volume":"27","author":"Ho","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0250","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1126\/science.1063097","article-title":"A circadian output in Drosophila mediated by neurofibromatosis-1 and Ras\/MAPK","volume":"293","author":"Williams","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0255","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.celrep.2014.07.054","article-title":"Modulation of cAMP and Ras signaling pathways improves distinct behavioral deficits in a zebrafish model of neurofibromatosis type 1","volume":"8","author":"Wolman","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0260","first-page":"881","article-title":"Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development","volume":"5","author":"Shin","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0265","doi-asserted-by":"crossref","first-page":"22305","DOI":"10.1073\/pnas.0901932106","article-title":"Cardiac and vascular functions of the zebrafish orthologues of the type I neurofibromatosis gene NFI","volume":"106","author":"Padmanabhan","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0270","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2302\/kjm.2013-0002-RE","article-title":"Legius syndrome, an update. Molecular pathology of mutations in SPRED1","volume":"62","author":"Brems","year":"2013","journal-title":"Keio J. Med."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0275","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1101\/gad.190876.112","article-title":"A shared molecular mechanism underlies the human rasopathies Legius syndrome and neurofibromatosis-1","volume":"26","author":"Stowe","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0280","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/ocr.12144","article-title":"A review of craniofacial and dental findings of the RASopathies","volume":"20","author":"Cao","year":"2017","journal-title":"Orthod. Craniofacial Res."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0285","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ng2113","article-title":"Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1\u2013like phenotype","volume":"39","author":"Brems","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0290","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/35088082","article-title":"Spred is a Sprouty-related suppressor of Ras signalling","volume":"412","author":"Wakioka","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0295","doi-asserted-by":"crossref","first-page":"14443","DOI":"10.1523\/JNEUROSCI.4698-08.2008","article-title":"Spred1 is required for synaptic plasticity and hippocampus-dependent learning","volume":"28","author":"Denayer","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0300","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1084\/jem.20040616","article-title":"Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness","volume":"201","author":"Inoue","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0305","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1101\/gad.1839510","article-title":"Spred1, a negative regulator of Ras-MAPK-ERK, is enriched in CNS germinal zones, dampens NSC proliferation, and maintains ventricular zone structure","volume":"24","author":"Phoenix","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0310","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1542\/peds.2009-3207","article-title":"Noonan syndrome: clinical features, diagnosis, and management guidelines","volume":"126","author":"Romano","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0315","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","article-title":"Noonan syndrome","volume":"381","author":"Roberts","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbabio.2018.05.003_bb0320","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng0102-123d","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome|nature genetics","volume":"30","author":"Tartaglia","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0325","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1926","article-title":"Germline gain-of-function mutations in SOS1 cause Noonan syndrome","volume":"39","author":"Roberts","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0330","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng1939","article-title":"Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome","volume":"39","author":"Tartaglia","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0335","first-page":"57","article-title":"Genetic and Pathogenetic aspects of Noonan syndrome and related disorders","volume":"72","author":"Zenker","year":"2009","journal-title":"Horm. Res."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0340","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng2078","article-title":"Germline gain-of-function mutations in RAF1 cause Noonan syndrome","volume":"39","author":"Razzaque","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0345","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1748","article-title":"Germline KRAS mutations cause Noonan syndrome","volume":"38","author":"Schubbert","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0350","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng.497","article-title":"A restricted spectrum of NRAS mutations causes Noonan syndrome","volume":"42","author":"Cirstea","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0355","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.425","article-title":"Mutation of SHOC2 promotes aberrant protein n-myristoylation and causes Noonan-like syndrome with loose anagen hair","volume":"41","author":"Cordeddu","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0360","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ajhg.2010.06.015","article-title":"Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype","volume":"87","author":"Martinelli","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0365","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng.641","article-title":"Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia","volume":"42","author":"Niemeyer","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0370","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.sjbs.2014.10.002","article-title":"BRAF gene: from human cancers to developmental syndromes","volume":"22","author":"Hussain","year":"2015","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0375","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jmedgenet-2015-103018","article-title":"Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome","volume":"52","author":"Yamamoto","year":"2015","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0380","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/jhg.2015.114","article-title":"Recent advances in RASopathies","volume":"61","author":"Aoki","year":"2016","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0385","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1093\/hmg\/ddu148","article-title":"Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis","volume":"23","author":"Flex","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0390","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ajhg.2013.05.021","article-title":"Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS\/MAPK pathway syndrome","volume":"93","author":"Aoki","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0395","doi-asserted-by":"crossref","first-page":"15436","DOI":"10.1073\/pnas.0903302106","article-title":"Noonan syndrome is associated with enhanced pERK activity, the repression of which can prevent craniofacial malformations","volume":"106","author":"Nakamura","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0400","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1242\/dmm.007112","article-title":"Noonan syndrome gain-of-function mutations in NRAS cause zebrafish gastrulation defects","volume":"4","author":"Runtuwene","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0405","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.devcel.2010.03.009","article-title":"Phosphatase-dependent and -independent functions of Shp2 in neural crest cells underlie LEOPARD syndrome pathogenesis","volume":"18","author":"Stewart","year":"2010","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0030225","article-title":"Shp2 knockdown and Noonan\/LEOPARD mutant Shp2\u2013induced gastrulation defects","volume":"3","author":"Jopling","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0415","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm1084","article-title":"Mouse model of Noonan syndrome reveals cell type\u2013 and gene dosage\u2013dependent effects of Ptpn11 mutation","volume":"10","author":"Araki","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0420","doi-asserted-by":"crossref","first-page":"16395","DOI":"10.1073\/pnas.1418126111","article-title":"K-Ras V14I recapitulates Noonan syndrome in mice","volume":"111","author":"Hern\u00e1ndez-Porras","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0425","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/nn.3863","article-title":"Mechanism and treatment for learning and memory deficits in mouse models of Noonan syndrome","volume":"17","author":"Lee","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0430","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.cell.2009.08.033","article-title":"The phosphatase SHP2 regulates the spacing effect for long-term memory induction","volume":"139","author":"Pagani","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0435","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1523\/JNEUROSCI.3515-13.2014","article-title":"The protein tyrosine phosphatase Shp2 is required for the generation of oligodendrocyte progenitor cells and myelination in the mouse telencephalon","volume":"34","author":"Ehrman","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0440","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1074\/jbc.M804129200","article-title":"Noonan syndrome\/leukemia-associated gain-of-function mutations in SHP-2 phosphatase ( PTPN11 ) enhance cell migration and angiogenesis","volume":"284","author":"Wang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0445","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-3-13","article-title":"Leopard syndrome","volume":"3","author":"Sarkozy","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0450","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1288\/00005537-197110000-00015","article-title":"The leopard (multiple lentigines) syndrome revisited","volume":"81","author":"Gorlin","year":"1971","journal-title":"Laryngoscope"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0455","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ajmg.a.31156","article-title":"LEOPARD syndrome: clinical diagnosis in the first year of life","volume":"140A","author":"Digilio","year":"2006","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0460","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0465","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.M513068200","article-title":"PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects","volume":"281","author":"Kontaridis","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0470","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/341528","article-title":"Grouping of multiple-Lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene","volume":"71","author":"Digilio","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0475","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/hmg\/ddn336","article-title":"Phosphatase-defective LEOPARD syndrome mutations in PTPN11 gene have gain-of-function effects during Drosophila development","volume":"18","author":"Oishi","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0480","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1152\/japplphysiol.00008.2014","article-title":"The Q510E mutation in Shp2 perturbs heart valve development by increasing cell migration","volume":"118","author":"Edwards","year":"2015","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0485","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI44972","article-title":"Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome\u2013associated PTPN11 mutation","volume":"121","author":"Marin","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0490","doi-asserted-by":"crossref","first-page":"H231","DOI":"10.1152\/ajpheart.00665.2011","article-title":"The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling","volume":"302","author":"Schramm","year":"2012","journal-title":"AJP Heart Circ. Physiol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0495","doi-asserted-by":"crossref","first-page":"E4494","DOI":"10.1073\/pnas.1406107111","article-title":"LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesity","volume":"111","author":"Tajan","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0500","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1038\/onc.2012.571","article-title":"Involvement of EphA2-mediated tyrosine phosphorylation of Shp2 in Shp2-regulated activation of extracellular signal-regulated kinase","volume":"32","author":"Miura","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0505","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ajmg.a.34419","article-title":"Characterization of a novel KRAS mutation identified in Noonan syndrome","volume":"158A","author":"Razzaque","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0510","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1242\/dev.106310","article-title":"Noonan and LEOPARD syndrome Shp2 variants induce heart displacement defects in zebrafish","volume":"141","author":"Bonetti","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0515","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/379793","article-title":"Capillary malformation\u2013arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations","volume":"73","author":"Eerola","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0520","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.gde.2005.03.004","article-title":"RASA1: variable phenotype with capillary and arteriovenous malformations","volume":"15","author":"Boon","year":"2005","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0525","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/ajmg.a.37613","article-title":"RASA1 somatic mutation and variable expressivity in capillary malformation\/arteriovenous malformation (CM\/AVM) syndrome","volume":"170","author":"Macmurdo","year":"2016","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0530","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/humu.20746","article-title":"Parkes weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused byRASA1 mutations","volume":"29","author":"Revencu","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0535","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1172\/JCI46116","article-title":"RASA1 maintains the lymphatic vasculature in a quiescent functional state in mice","volume":"122","author":"Lapinski","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0540","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/377695a0","article-title":"Vascular system defects and neuronal apoptosis in mice lacking Ras GTPase-activating protein","volume":"377","author":"Henkemeyer","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0545","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.ajpath.2014.08.018","article-title":"Blood vascular abnormalities in Rasa1R780Q Knockin mice","volume":"184","author":"Lubeck","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0550","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ajmg.a.33857","article-title":"Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: a Ras\/MAPK pathway syndrome","volume":"155","author":"Lin","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0555","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1399-0004.2007.00743.x","article-title":"HRAS and the Costello syndrome","volume":"71","author":"Rauen","year":"2007","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0560","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/gim.0b013e31822dd91f","article-title":"Costello syndrome: a Ras\/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations","volume":"14","author":"Gripp","year":"2012","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0565","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2133.2011.10744.x","article-title":"Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in development: dermatological phenotype and Ras dysregulation in Costello syndrome","volume":"166","author":"Siegel","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0570","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajmg.c.30065","article-title":"Tumor predisposition in Costello syndrome","volume":"137C","author":"Gripp","year":"2005","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0575","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajmg.a.31078","article-title":"HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy","volume":"140","author":"Estep","year":"2006","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0580","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/ng1641","article-title":"Germline mutations in HRAS proto-oncogene cause Costello syndrome","volume":"37","author":"Aoki","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0585","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/humu.20381","article-title":"Paternal bias in parental origin of HRAS mutations in Costello syndrome","volume":"27","author":"Sol-Church","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0590","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/humu.20431","article-title":"Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome","volume":"28","author":"Zampino","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0595","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/ajmg.a.31456","article-title":"Somatic mosaicism for anHRAS mutation causes Costello syndrome","volume":"140A","author":"Gripp","year":"2006","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0600","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ajmg.a.32639","article-title":"Male-to-male transmission of Costello syndrome: G12S HRAS germline mutation inherited from a father with somatic mosaicism","volume":"149A","author":"Sol-Church","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0605","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/ajmg.a.34150","article-title":"Molecular confirmation of HRAS p.G12S in siblings with Costello syndrome","volume":"155","author":"Gripp","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0610","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399408000902","article-title":"Noonan, Costello and cardio\u2013facio\u2013cutaneous syndromes: dysregulation of the Ras\u2013MAPK pathway","volume":"10","author":"Tidyman","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0615","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1073\/pnas.81.18.5704","article-title":"Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules","volume":"81","author":"Gibbs","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0620","doi-asserted-by":"crossref","first-page":"7979","DOI":"10.1073\/pnas.0900343106","article-title":"Endogenous expression of HrasG12V induces developmental defects and neoplasms with copy number imbalances of the oncogene","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0625","doi-asserted-by":"crossref","DOI":"10.1172\/JCI34385","article-title":"A mouse model for Costello syndrome reveals an Ang II\u2013mediated hypertensive condition","author":"Schuhmacher","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0630","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/hmg\/ddt455","article-title":"Abnormal Ras signaling in Costello syndrome (CS) negatively regulates enamel formation","volume":"23","author":"Goodwin","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0635","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1038\/onc.2013.489","article-title":"Transformation by HrasG12V is consistently associated with mutant allele copy gains and is reversed by farnesyl transferase inhibition","volume":"33","author":"Chen","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0640","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1601-183X.2008.00443.x","article-title":"Germline expression of H-Ras G12V causes neurological deficits associated to Costello syndrome","volume":"8","author":"Viosca","year":"2009","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0645","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1242\/dmm.001016","article-title":"Expression of H-RASV12 in a zebrafish model of Costello syndrome causes cellular senescence in adult proliferating cells","volume":"2","author":"Santoriello","year":"2009","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0650","series-title":"Monographs in Human Genetics","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000164845","article-title":"The molecular basis of costello syndrome","volume":"17","year":"2008"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0655","article-title":"Mice with an oncogenic HRAS mutation are resistant to high-fat diet-induced obesity and exhibit impaired hepatic energy homeostasis","author":"Oba","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0660","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2013-3189","article-title":"Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines","volume":"134","author":"Pierpont","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0665","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ng1749","article-title":"Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome","volume":"38","author":"Niihori","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0670","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1469-8749.2007.00894.x","article-title":"Neurological complications of cardio-facio-cutaneous syndrome","volume":"49","author":"Yoon","year":"2007","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0675","series-title":"Monographs in Human Genetics","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000164843","article-title":"Molecular causes of the cardio-facio-cutaneous syndrome","volume":"17","author":"Zenker","year":"2008"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0680","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1126\/science.1124642","article-title":"Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome","volume":"311","author":"Rodriguez-Viciana","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0685","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cell.2009.12.040","article-title":"Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF","volume":"140","author":"Heidorn","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0690","first-page":"546","article-title":"Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish","volume":"5","author":"Anastasaki","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0695","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ajmg.a.33342","article-title":"Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome: transmission through four generations","volume":"152A","author":"Rauen","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0700","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1073\/pnas.1016933108","article-title":"Constitutive activation of B-Raf in the mouse germ line provides a model for human cardio-facio-cutaneous syndrome","volume":"108","author":"Urosevic","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0705","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.1093\/hmg\/ddu376","article-title":"New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome","volume":"23","author":"Inoue","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0710","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1093\/hmg\/ddp186","article-title":"Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors","volume":"18","author":"Anastasaki","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0715","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1101\/gad.193458.112","article-title":"The intermediate-activity L597VBRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF\/MEK\/ERK pathway","volume":"26","author":"Andreadi","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0720","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.300.3.287","article-title":"Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial","volume":"300","author":"Krab","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0725","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neulet.2012.03.009","article-title":"Lovastatin regulates brain spontaneous low-frequency brain activity in neurofibromatosis type 1","volume":"515","author":"Chabernaud","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0730","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ajmg.c.30294","article-title":"Costello and cardio-facio-cutaneous syndromes: moving toward clinical trials in RASopathies","volume":"157","author":"Rauen","year":"2011","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0735","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1194\/jlr.R500012-JLR200","article-title":"Thematic review series: lipid posttranslational modifications. Farnesyl transferase inhibitors","volume":"47","author":"Basso","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0740","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ng2096","article-title":"RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis","volume":"39","author":"Shukla","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0745","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.bbabio.2010.02.030","article-title":"Multi-site control and regulation of mitochondrial energy production","volume":"1797","author":"Benard","year":"2010","journal-title":"Biochim. Biophys. Acta BBA - Bioenerg."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0750","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2006.05.003","article-title":"Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1","volume":"3","author":"Um","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0755","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cmet.2007.05.006","article-title":"S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase","volume":"5","author":"Aguilar","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0760","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0765","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nature07813","article-title":"AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity","volume":"458","author":"Cant\u00f3","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0770","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MOL.0b013e328328d0a4","article-title":"PGC-1\u03b1, SIRT1 and AMPK, an energy sensing network that controls energy expenditure","volume":"20","author":"Cant\u00f3","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0775","doi-asserted-by":"crossref","first-page":"30107","DOI":"10.1074\/jbc.M705325200","article-title":"The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor","volume":"282","author":"Greer","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0780","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cmet.2009.03.012","article-title":"AMPK: an emerging drug target for diabetes and the metabolic syndrome","volume":"9","author":"Zhang","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0785","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1126\/science.124.3215.267","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Weinhouse","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0790","series-title":"Mitochondria","author":"Scheffler","year":"1999"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0795","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0021-9258(19)57191-5","article-title":"Respiratory enzymes in oxidative phosphorylation III. The steady state","volume":"217","author":"Chance","year":"1955","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0800","series-title":"Advances in Enzymology - and Related Areas of Molecular Biology","first-page":"65","article-title":"The respiratory chain and oxidative phosphorylation","author":"Chance","year":"2006"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0805","doi-asserted-by":"crossref","first-page":"C1172","DOI":"10.1152\/ajpcell.00195.2006","article-title":"Physiological diversity of mitochondrial oxidative phosphorylation","volume":"291","author":"Benard","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0810","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1074\/mcp.M500014-MCP200","article-title":"The post-translational modifications of the nuclear encoded subunits of complex I from bovine heart mitochondria","volume":"4","author":"Carroll","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0815","doi-asserted-by":"crossref","first-page":"14471","DOI":"10.1021\/bi981500w","article-title":"The post-translational modification in cytochrome c oxidase is required to establish a functional environment of the catalytic site","volume":"37","author":"Das","year":"1998","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0820","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2013.08.032","article-title":"Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency","volume":"155","author":"Cogliati","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0825","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10863-009-9232-8","article-title":"Uncoupling protein-1 (UCP1) contributes to the basal proton conductance of brown adipose tissue mitochondria","volume":"41","author":"Parker","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0830","doi-asserted-by":"crossref","first-page":"11080","DOI":"10.1073\/pnas.97.20.11080","article-title":"High phosphorylation efficiency and depression of uncoupled respiration in mitochondria under hypoxia","volume":"97","author":"Gnaiger","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0835","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1242\/jcs.03381","article-title":"Mitochondrial bioenergetics and structural network organization","volume":"120","author":"Benard","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0840","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.biocel.2014.12.008","article-title":"Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy","volume":"59","author":"Obre","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0845","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0850","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0092-8674(84)90531-2","article-title":"Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells","volume":"38","author":"Feramisco","year":"1984","journal-title":"Cell"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0855","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1021\/pr200612y","article-title":"Proteomic profiling of H-Ras-G12V induced hypertrophic cardiomyopathy in transgenic mice using comparative LC-MS analysis of thin fresh-frozen tissue sections","volume":"11","author":"Wei","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0860","article-title":"Glucose starvation induces cell death in K-ras-transformed cells by interfering with the hexosamine biosynthesis pathway and activating the unfolded protein response","volume":"4","author":"Palorini","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0865","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1171721","article-title":"Mitochondrial STAT3 supports Ras-dependent oncogenic transformation","volume":"324","author":"Gough","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0870","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1476-4598-6-77","article-title":"The oncoprotein H-RasV12 increases mitochondrial metabolism","volume":"6","author":"Telang","year":"2007","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0875","doi-asserted-by":"crossref","first-page":"10609","DOI":"10.1074\/jbc.273.17.10609","article-title":"Importance of glucose-6-phosphate dehydrogenase activity for cell growth","volume":"273","author":"Tian","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0880","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrc.2016.77","article-title":"Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?","volume":"16","author":"Hay","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0885","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1158\/1078-0432.CCR-14-2425","article-title":"Metabolic dependencies in RAS-driven cancers","volume":"21","author":"Kimmelman","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0890","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.trecan.2015.10.001","article-title":"Targeting RAS-mutant cancers: is ERK the key?","volume":"1","author":"Ryan","year":"2015","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0895","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1074\/jbc.M112.378984","article-title":"The import of the transcription factor STAT3 into mitochondria depends on GRIM-19, a component of the electron transport chain","volume":"288","author":"Tammineni","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0900","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1126\/science.1164551","article-title":"Function of mitochondrial Stat3 in cellular respiration","volume":"323","author":"Wegrzyn","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0905","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-6670-7_2","article-title":"Senescence phenotypes induced by Ras in primary cells","volume":"1534","author":"Lau","year":"2017","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0910","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1128\/MCB.01868-08","article-title":"Mitochondrial dysfunction contributes to oncogene-induced senescence","volume":"29","author":"Moiseeva","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0915","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1038\/ncomms6264","article-title":"Mitochondrial defects trigger proliferation of neighbouring cells via a senescence-associated secretory phenotype in Drosophila","volume":"5","author":"Nakamura","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0920","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1006\/bbrc.1997.6835","article-title":"Effect of oncogene transformation of rat embryo cells on cellular oxygen consumption and glycolysis","volume":"235","author":"Biaglow","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0925","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ebiom.2017.03.020","article-title":"Mitochondria in cell senescence: is mitophagy the weakest link?","volume":"21","author":"Korolchuk","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0930","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.4161\/auto.7.10.16643","article-title":"Involvement of mitophagy in oncogenic K-Ras-induced transformation: overcoming a cellular energy deficit from glucose deficiency","volume":"7","author":"Kim","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0935","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4161\/auto.6458","article-title":"Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease","volume":"4","author":"Dagda","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0940","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.1038\/sj.onc.1208003","article-title":"Ras-dependent induction of HIF-1\u03b1785 via the Raf\/MEK\/ERK pathway: a novel mechanism of Ras-mediated tumor promotion","volume":"23","author":"Lim","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0945","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","article-title":"Hypoxia-inducible factors and the response to hypoxic stress","volume":"40","author":"Majmundar","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0950","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0955","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","article-title":"HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption","volume":"3","author":"Papandreou","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0960","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.123","article-title":"Cancer metabolism: current perspectives and future directions","volume":"3","author":"Mu\u00f1oz-Pinedo","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0965","doi-asserted-by":"crossref","first-page":"20281","DOI":"10.1074\/jbc.274.29.20281","article-title":"Regulation of GLUT1 gene transcription by the serine\/threonine kinase Akt1","volume":"274","author":"Barthel","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0970","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1038\/sj.onc.1209595","article-title":"Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt","volume":"25","author":"Robey","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0975","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1101\/gad.889901","article-title":"Inhibition of early apoptotic events by Akt\/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase","volume":"15","author":"Gottlob","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0980","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"D\u00fcvel","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbabio.2018.05.003_bb0985","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.tem.2010.01.001","article-title":"The Akt\u2013SREBP nexus: cell signaling meets lipid metabolism","volume":"21","author":"Krycer","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0990","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/excr.2002.5600","article-title":"Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase","volume":"279","author":"Yang","year":"2002","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbabio.2018.05.003_bb0995","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mc.22079","article-title":"Altered glucose metabolism in Harvey-ras transformed MCF10A cells: altered glucose metabolism in harvey-ras transformed cells","volume":"54","author":"Zheng","year":"2015","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1000","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ijc.28798","article-title":"Ha-ras and \u03b2-catenin oncoproteins orchestrate metabolic programs in mouse liver tumors: Ha-ras and \u03b2-catenin oncoproteins","volume":"135","author":"Unterberger","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1005","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1015","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1101\/gad.2016311","article-title":"Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis","volume":"25","author":"Guo","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1476-4598-8-54","article-title":"Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12\/E1A transformed fibroblasts that develop a Warburg phenotype","volume":"8","author":"de Groof","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1025","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1073\/pnas.1003428107","article-title":"Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity","volume":"107","author":"Weinberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1030","doi-asserted-by":"crossref","first-page":"14857","DOI":"10.1074\/jbc.M709098200","article-title":"Isoform-specific interaction of C-RAF with mitochondria","volume":"283","author":"Galmiche","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1035","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.tcb.2008.09.006","article-title":"Control of mitochondria dynamics and oxidative metabolism by cAMP, AKAPs and the proteasome","volume":"18","author":"Carlucci","year":"2008","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1040","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1128\/MCB.05255-11","article-title":"Kinase suppressor of ras 1 (KSR1) regulates PGC1\u03b1 and estrogen-related receptor \u03b1 to promote oncogenic Ras-dependent anchorage-independent growth","volume":"31","author":"Fisher","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1045","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1074\/jbc.M114.596551","article-title":"A novel MEK-ERK-AMPK signaling axis controls chemokine receptor CCR7-dependent survival in human mature dendritic cells","volume":"290","author":"L\u00f3pez-Cotarelo","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.phrs.2016.02.009","article-title":"Targeting metabolic reprogramming as a potential therapeutic strategy in melanoma","volume":"107","author":"Smith","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1055","doi-asserted-by":"crossref","first-page":"969","DOI":"10.18632\/oncotarget.2824","article-title":"Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer","volume":"6","author":"Vujic","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1060","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1158\/0008-5472.CAN-14-1392","article-title":"Inhibition of mTORC1\/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1 and oxidative phosphorylation in melanoma","volume":"74","author":"Gopal","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1065","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0006-291X(02)00391-1","article-title":"Activation of Ras cascade increases the mitochondrial enzyme content of respiratory competent yeast","volume":"293","author":"Dejean","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrc2109","article-title":"Hyperactive Ras in developmental disorders and cancer","volume":"7","author":"Schubbert","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","article-title":"The COSMIC (catalogue of somatic mutations in Cancer) database and website","volume":"91","author":"Bamford","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1080","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/msb.2011.56","article-title":"Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth","volume":"7","author":"Gaglio","year":"2014","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1085","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1126\/science.aaa5004","article-title":"Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH","volume":"350","author":"Yun","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1090","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1095","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2016.01.007","article-title":"Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer","volume":"23","author":"Davidson","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1105","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.4161\/cc.25307","article-title":"Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance","volume":"12","author":"Lyssiotis","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tibs.2013.12.004","article-title":"KRAS: feeding pancreatic cancer proliferation","volume":"39","author":"Bryant","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1115","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0003-9861(91)90084-V","article-title":"Regulation of 6-phosphofructo-1-kinase activity in ras-transformed rat-1 fibroblasts","volume":"286","author":"Kole","year":"1991","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1120","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.celrep.2017.06.061","article-title":"A role for mitochondrial translation in promotion of viability in K-Ras mutant cells","volume":"20","author":"Martin","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1125","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/01.wnl.0000244435.27645.54","article-title":"Mitochondrial disease criteria diagnostic applications in children","volume":"67","author":"Morava","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1130","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1373\/clinchem.2005.062414","article-title":"Measurement of the energy-generating capacity of human muscle mitochondria: diagnostic procedure and application to human pathology","volume":"52","author":"Janssen","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1135","first-page":"385","article-title":"Mitochondrial cardiomyopathy","volume":"40","author":"Meyers","year":"2013","journal-title":"Tex. Heart Inst. J."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1140","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0195-668X(02)00387-1","article-title":"Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings","volume":"24","author":"Holmgren","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1145","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.2006-1866","article-title":"Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases","volume":"119","author":"Debray","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1150","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.pediatrneurol.2007.12.001","article-title":"Presentation and diagnosis of mitochondrial disorders in children","volume":"38","author":"Koenig","year":"2008","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1155","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF01799112","article-title":"Clinical presentation of mitochondrial disorders in childhood","volume":"19","author":"Munnich","year":"1996","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1160","first-page":"286","article-title":"Renal disease and mitochondrial genetics","volume":"16","author":"R\u00f6tig","year":"2003","journal-title":"J. Nephrol."},{"issue":"Pt 5","key":"10.1016\/j.bbabio.2018.05.003_bb1165","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/brain\/109.5.915","article-title":"The clinical features of mitochondrial myopathy","volume":"109","author":"Petty","year":"1986","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1170","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1212\/01.WNL.0000033795.17156.00","article-title":"Diagnostic criteria for respiratory chain disorders in adults and children","volume":"59","author":"Bernier","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1196\/annals.1338.004","article-title":"Hearing loss in mitochondrial disorders","volume":"1042","author":"Hsu","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1180","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/01.bor.0000245729.17759.f2","article-title":"Mitochondrial myopathies","volume":"18","author":"DiMauro","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1185","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/1756283X16666806","article-title":"Gastrointestinal manifestations of mitochondrial disorders: a systematic review","volume":"10","author":"Finsterer","year":"2017","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1190","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000443556","article-title":"Fatty acid beta-oxidation disorders: a brief review","volume":"23","author":"Vishwanath","year":"2016","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1195","series-title":"Physician's Guide to the Diagnosis, Treatment and Follow-Up of Inherited Metabolic Diseases","author":"Blau","year":"2014"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1200","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev.physiol.64.082201.154705","article-title":"Fatty acid oxidation disorders","volume":"64","author":"Rinaldo","year":"2002","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1205","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/MCB.05806-11","article-title":"Loss of Akt1 in mice increases energy expenditure and protects against diet-induced obesity","volume":"32","author":"Wan","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1215","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1128\/MCB.00722-06","article-title":"Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies","volume":"26","author":"Dummler","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1220","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1210\/endo.143.3.8687","article-title":"Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gene transcription in insulin-induced differentiation of C2C12 myoblasts","volume":"143","author":"Sumitani","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1225","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00246-010-9879-2","article-title":"Akt2: a critical regulator of cardiomyocyte survival and metabolism","volume":"32","author":"Muslin","year":"2011","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1230","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mce.2012.03.018","article-title":"Differential function of Akt1 and Akt2 in human adipocytes","volume":"358","author":"Fischer-Posovszky","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1235","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijcard.2006.07.229","article-title":"Novel mitochondrial DNA mutations implicated in Noonan syndrome","volume":"120","author":"Dhandapany","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.mito.2009.12.146","article-title":"Mitochondrial DNA haplogroup \u2018R\u2019 is associated with Noonan syndrome of South India","volume":"10","author":"Rani","year":"2010","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1245","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbadis.2009.10.005","article-title":"A suggested role for mitochondria in Noonan syndrome","volume":"1802","author":"Lee","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1250","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s00018-004-4211-z","article-title":"Tyrosine phosphatase activity in mitochondria: presence of Shp-2 phosphatase in mitochondria","volume":"61","author":"Salvi","year":"2004","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1255","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/ejhg.2010.171","article-title":"Mitochondrial dysfunction and organic aciduria in five patients carrying mutations in the Ras-MAPK pathway","volume":"19","author":"Kleefstra","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1260","article-title":"Activating mutations in protein tyrosine phosphatase Ptpn11 (Shp2) enhance reactive oxygen species production that contributes to myeloproliferative disorder","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbabio.2018.05.003_bb1265","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1038\/s41467-017-02351-0","article-title":"Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis","volume":"8","author":"Guo","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1270","doi-asserted-by":"crossref","first-page":"16064","DOI":"10.1073\/pnas.0405041101","article-title":"Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism","volume":"101","author":"Zhang","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1275","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.celrep.2016.12.056","article-title":"Absence of neurofibromin induces an oncogenic metabolic switch via mitochondrial ERK-mediated phosphorylation of the chaperone TRAP1","volume":"18","author":"Masgras","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1280","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1073\/pnas.0912742107","article-title":"Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition","volume":"107","author":"Rasola","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1285","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/hmg\/ddt515","article-title":"NF1 is a critical regulator of muscle development and metabolism","volume":"23","author":"Sullivan","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1290","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jpeds.2015.11.076","article-title":"Understanding growth failure in Costello syndrome: increased resting energy expenditure","volume":"170","author":"Leoni","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1295","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/jmg.2007.049270","article-title":"Myopathy caused by HRAS germline mutations: implications for disturbed myogenic differentiation in the presence of constitutive HRas activation","volume":"44","author":"van der Burgt","year":"2007","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1300","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/ejhg.2015.175","article-title":"The lymphatic phenotype in Noonan and cardiofaciocutaneous syndrome","volume":"24","author":"Joyce","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1305","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s10545-007-0612-0","article-title":"Cardiofaciocutaneous (CFC) syndrome associated with muscular coenzyme Q10 deficiency","volume":"30","author":"Aeby","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbabio.2018.05.003_bb1310","first-page":"1917","article-title":"Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts","volume":"6","author":"Land","year":"1986","journal-title":"Mol. Cell. Biol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Bioenergetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005272818301063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005272818301063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T08:22:39Z","timestamp":1757751759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0005272818301063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":262,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0005272818301063"],"URL":"https:\/\/doi.org\/10.1016\/j.bbabio.2018.05.003","relation":{},"ISSN":["0005-2728"],"issn-type":[{"value":"0005-2728","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RAS signalling in energy metabolism and rare human diseases","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Bioenergetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbabio.2018.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}